Home › Agent Hub › Agent Tools › Part D coverage by drug › Nystatin / Triamcinolone
Agent Tools
Nystatin / Triamcinolone is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 2,681 of 5,492 Medicare Part D and Medicare Advantage drug plans (48.8%) list Nystatin / Triamcinolone on their formulary, across 198 of 286 formularies. The most common placement is tier 4 (1,594 plans, 59.5% of those covering it). 0 of the covering plans require prior authorization (0%), 0 step therapy and 844 a quantity limit.
908 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $5, 330 of them $0; 1,773 charge coinsurance instead — median 30% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 2,750 of 5,496 plans covered it (50%); 2027: 2,681 of 5,492 (48.8%).
Of 4,367 plans offered in both years, 100 added it to the formulary and 14 dropped it.
Among plans covering it both years, 77 moved it to a higher tier and 88 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 217 |
| Tier 2 | 744 |
| Tier 3 | 126 |
| Tier 4 | 1,594 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 191 of 323 | 59.1% | 0% |
| Medicare Advantage with drugs (MA-PD) | 1,640 of 3,200 | 51.2% | 0% |
| Special needs plans (SNP) | 850 of 1,969 | 43.2% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 4 | 0 |
| UnitedHealthcare | 39 of 830 | Tier 4 | 0 |
| Devoted Health | 0 of 728 | No tier listed | 0 |
| Aetna Medicare | 0 of 631 | No tier listed | 0 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 226 of 226 | Tier 4 | 0 |
| Kaiser Permanente | 112 of 112 | Tier 2 | 0 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 2 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 4 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 4 | 0 |
| Wellpoint | 63 of 63 | Tier 4 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 2 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 4 | 0 |
| Zing Health | 0 of 36 | No tier listed | 0 |
| Capital Blue Cross | 35 of 35 | Tier 4 | 0 |
| Prominence Health Plan | 0 of 29 | No tier listed | 0 |
| Medica | 27 of 27 | Tier 2 | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 4 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 2 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 44 of 114 | 38.6% |
| Alaska | 5 of 9 | 55.6% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 75 of 147 | 51% |
| Arkansas | 35 of 85 | 41.2% |
| California | 304 of 397 | 76.6% |
| Colorado | 52 of 106 | 49.1% |
| Connecticut | 15 of 54 | 27.8% |
| Delaware | 19 of 43 | 44.2% |
| District of Columbia | 4 of 12 | 33.3% |
| Florida | 250 of 545 | 45.9% |
| Georgia | 76 of 149 | 51% |
| Guam | 1 of 1 | 100% |
| Hawaii | 17 of 50 | 34% |
| Idaho | 14 of 45 | 31.1% |
| Illinois | 50 of 132 | 37.9% |
| Indiana | 66 of 138 | 47.8% |
| Iowa | 24 of 64 | 37.5% |
| Kansas | 30 of 84 | 35.7% |
| Kentucky | 66 of 121 | 54.5% |
| Louisiana | 56 of 125 | 44.8% |
| Maine | 22 of 52 | 42.3% |
| Maryland | 24 of 49 | 49% |
| Massachusetts | 55 of 89 | 61.8% |
| Michigan | 122 of 182 | 67% |
| Minnesota | 30 of 63 | 47.6% |
| Mississippi | 38 of 104 | 36.5% |
| Missouri | 64 of 170 | 37.6% |
| Montana | 19 of 27 | 70.4% |
| Nebraska | 17 of 51 | 33.3% |
| Nevada | 53 of 100 | 53% |
| New Hampshire | 11 of 25 | 44% |
| New Jersey | 30 of 73 | 41.1% |
| New Mexico | 24 of 68 | 35.3% |
| New York | 75 of 215 | 34.9% |
| North Carolina | 83 of 176 | 47.2% |
| North Dakota | 15 of 26 | 57.7% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 81 of 171 | 47.4% |
| Oklahoma | 41 of 81 | 50.6% |
| Oregon | 45 of 92 | 48.9% |
| Pennsylvania | 208 of 323 | 64.4% |
| Puerto Rico | 64 of 64 | 100% |
| Rhode Island | 5 of 29 | 17.2% |
| South Carolina | 47 of 89 | 52.8% |
| South Dakota | 17 of 30 | 56.7% |
| Tennessee | 53 of 156 | 34% |
| Texas | 184 of 407 | 45.2% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 23 of 53 | 43.4% |
| Vermont | 9 of 14 | 64.3% |
| Virginia | 74 of 144 | 51.4% |
| Washington | 53 of 114 | 46.5% |
| West Virginia | 44 of 69 | 63.8% |
| Wisconsin | 56 of 96 | 58.3% |
| Wyoming | 9 of 13 | 69.2% |
Medicare Part D paid for 265,098 30-day fills of Nystatin / Triamcinolone in 2024 for about 155,683 enrollees, at an average total cost of $26.16 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Nystatin / Triamcinolone and the rest of a client's list on every plan in their county.
Estimate Nystatin / Triamcinolone costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.